Sterling Medical Devices Merges with RBC Medical Innovations — Forming Vantage MedTech to Strengthen MedTech Services

In a significant move within the medical technology industry, Sterling Medical Devices and RBC Medical Innovations have officially merged and rebranded under the new name Vantage MedTech — a combined entity designed to offer end-to-end services for medical device innovators and OEM partners.

The merger, completed in early 2023, brings together two well-established organizations with decades of collective experience in medical device design, engineering, regulatory strategy, and manufacturing. With support from private equity firm Ampersand Capital Partners, the combined company aims to deliver a broader, more integrated suite of solutions spanning the entire product lifecycle — from initial concept to commercial production.

Why the Merger Matters for the MedTech Industry

Sterling Medical Devices has been recognized for more than two decades for its work in custom electromechanical system development, software integration, and regulatory support for medical device projects. Meanwhile, RBC Medical Innovations brought deep expertise in energy-based technologies and manufacturing execution to the table. The strategic combination of these capabilities allows the new entity, Vantage MedTech, to offer a more holistic service platform.

According to industry sources, Vantage MedTech now serves clients ranging from early-stage startups to large multinational OEMs, supporting accelerated product realization and commercialization.

Leadership and Strategic Direction

As part of the merger, experienced MedTech executive David Montecalvo was named Chief Executive Officer of the combined company. Montecalvo brings more than 35 years of leadership experience in the medical technology sector, including tenure at established device companies. Sterling’s founder — Dan Sterling — and RBC’s founder — Carl Mayer — remain actively involved as senior leadership and board members, ensuring continuity and deep domain knowledge across both legacy organizations.

Industry analysts note that the leadership blend — combining legacy experience with strategic private equity support — positions Vantage MedTech to navigate evolving global regulatory demands while addressing market needs for faster time-to-market and quality compliance.

Expanded Capabilities Under One Roof

The rebranded organization combines the strengths of both legacy companies across multiple competencies, including:

• Product Development & Engineering

Comprehensive design and prototyping support, from conceptual sketches to functional prototypes, with expertise in electromechanical, software, and complex system integration.

• Regulatory Strategy & Quality

Guidance on regulatory pathways, quality system design, and submission support across major jurisdictions such as the U.S., EU, and Asia.

• Manufacturing & Scale-Up

Clinical and commercial manufacturing capabilities that serve low-volume clinical builds through full-scale production, backed by quality-certified facilities and robust process controls.

• Commercialization Support

Services that help bridge the gap between development and market launch, including labeling guidance, supply chain planning, and post-market support structures.

This integrated approach allows Vantage MedTech to position itself as a one-stop partner for medical device companies looking to streamline complex development programs and reduce time-to-market.

Brand Vision: Faster, More Integrated MedTech Solutions

The merger announcement emphasized that the new brand — Vantage MedTech — reflects a commitment to innovation and collaboration across the medical technology landscape. By combining engineering depth, manufacturing scale, and quality expertise, the organization aims to help clients navigate common development hurdles and deliver safe, effective medical devices efficiently.

The expanded service portfolio also underscores a shift toward platform-based development methodologies, where existing engineering frameworks and modular systems can be adapted to accelerate new device programs.

Industry Impact and Client Benefits

For MedTech OEMs and innovation teams, the merger delivers several practical advantages:

• Broader Technical Capabilities: Access to a larger pool of engineers with diverse expertise across hardware, software, and electromechanical domains.

• Streamlined Development Pathways: Continuous support from early feasibility studies through verification, validation, and production.

• Regulatory and Quality Integration: Quality system design and regulatory planning embedded into development workflows.

• Scalable Manufacturing Solutions: Ability to support both clinical builds and high-volume production with consistent quality systems.

These benefits align with broader industry trends where medical device companies increasingly seek end-to-end partners capable of reducing complexity and risk throughout the product lifecycle.

Looking Ahead: What’s Next for Vantage MedTech

Following the merger and rebrand, the company has continued to invest in digital presence and client engagement. In early 2024, the organization launched an enhanced web platform highlighting its life-cycle services and expanded capabilities, solidifying its position as an integrated MedTech partner.

Industry observers expect that Vantage MedTech will continue to refine its offerings with an emphasis on advanced technologies — including connected devices, software-driven platforms, and data-enabled development tools — as global demand for innovative medical technologies grows.

Conclusion

The merger between Sterling Medical Devices and RBC Medical Innovations — culminating in the creation of Vantage MedTech — marks a significant development in the medical device services landscape. By combining decades of expertise in design, regulatory strategy, and manufacturing, the newly formed organization positions itself as a comprehensive development and manufacturing partner capable of helping MedTech companies navigate the complexities of bringing life-changing devices to market